Introduction: Primary ovarian neoplasms exhibit a wide range of clinical and
histopathological presentations. Tumors showing epithelial differentiation are the most …

Ovarian cancer is the leading cause of death in women with pelvic malignancies. Because
of the multiple histologic types of malignancy that can arise within the ovary, accurate …

The presence of CA125 was assessed in peritoneal fluid from 70 patients with ovarian
cancer and 32 control patients. The follow-up period ranged from 39 to 89 months (median …

A tumour-associated trypsin inhibitor (TATI) and the cancer antigen 125 (CA 125) were
measured pre-or peroperatively in 30 patients with mucinous ovarian tumours (10 …

Human chorionic gonadotropin is a highly sensitive and specific tumour marker for
gestational trophoblastic disease and reflects accurately tumour volume and clinical course …

Das Ovarialkarzinom ist das vierthäufigste Malignom der europäischen Frau, nimmt aber mit
seiner schlechten Prognose den 1. Platz in der Mortalitätsstatistik der gynäkologischen …

目的: 探讨卵巢上皮性癌血清CA125, CA72-4, 铜锌超氧化物歧化酶(Cu. Zn-SOD)
水平测定的临床意义. 方法: 采用放射免疫法测定42 例卵巢上皮性癌患者, 66 …

Monoclonal antibodies (McAbs), reactive with tumour-associated antigens (TAAs) present
on tumour cells, appear to offer new possibilities in the diagnosis and treatment of cancer …

Defined as substances synthesised by tumour cellsand released into the bloodstream of
patients with cancer, serum tumour markers have proven to be of significant clinical benefit …

A review of the literature was done to assess the evidence for ovarian cancer screening, and
the effectiveness of the different methods of screening. There is not yet sufficient evidence …